By skyforbes 
About a year ago I touted MDGL for their drug Rezdiffra and a lot has changed for the stock since then, but it’s still has a lot of potential. There’s already studies research its impact in combination with other therapies and further expansion. I liked the stock then. I like the stock now. I’m still holding up 162%.
Here is my post from last year going thru it all. There’s some doubters in the comments there too: https://www.reddit.com/r/wallstreetbets/s/YpcJ4R98fK